Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Iliver|October 7, 2025
Nucleic acid therapeutics for liver diseases: A decade of technological convergence and clinical challengesYufei Pan, Mingyue Pan, Yuanzheng Huang, et al.
Iliver|September 22, 2025
Debates and progress in the management of intermediate-stage (BCLC stage B) hepatocellular carcinomaJianan Jiang, Yinbiao Cao, Shang Gao, et al.
Iliver|September 10, 2025
Progress on Laennec's capsule guidance for hepatobiliary surgeryDecai Yu, Leizhou Xia
Iliver|December 4, 2025
Coagulation abnormalities in children with chronic liver disease and the association of these abnormalities with disease severityRubaiyat Alam, Mst Arifa Main, Khan Lamia Nahid, et al.
Iliver|December 1, 2025
From thrombosis to transplantation: The role of anti-phospholipid antibodies in liver disease managementDante Pio Pallotta, Eugenio Franceschini, Maria Boe, et al.
Iliver|May 25, 2026
Heterogeneity of hepatic macrophages in MASLD/MASH: Lipid-associated programs, molecular mechanisms, spatial niches, and therapeutic implicationsKaipeng Hu, Siyuan Liu, Shuyan Sheng, et al.
Iliver|February 24, 2026
Single-port robot-assisted hepatectomy of segments S4b and S5v: A case reportXin Lan, Jian Feng, Chenglin Piao, et al.
Iliver|February 27, 2026
Development of a hybrid deep learning-based framework for liver fibrosis classification using ultrasound imagesAdedotun F Adesina, Blessing O Olorunfemi, Adenike T Adeniji-Sofoluwe, et al.
Iliver|June 12, 2026
Medical imaging-derived artificial intelligence for prognostic stratification and treatment response prediction in interventional therapy of hepatocellular carcinomaYing Lei, Tianyi Xia, Yawen Wang, et al.
Iliver|June 3, 2026
Targeting tumor-associated macrophages in pancreatic cancerYuxi Long, Luoyingzi Xie, Fuming Xie, et al.
Pageof 5